Article Information
- Received August 14, 2019
- Revision received March 13, 2020
- Accepted March 17, 2020
- Published online April 23, 2020.
Author Information
- Rémi Opsomer1,
- Sabrina Contino1,*,
- Florian Perrin1,2,*,
- Roberta Gualdani4,
- Bernadette Tasiaux1,
- Pierre Doyen3,
- Maxime Vergouts3,
- Céline Vrancx1,
- Anna Doshina1,
- Nathalie Pierrot1,
- Jean-Noël Octave1,
- Philippe Gailly4,
- Serena Stanga1 and
- Pascal Kienlen-Campard1
- 1CEllular and MOlecular Division-Alzheimer Dementia group, Institute of Neuroscience
- 2de Duve Institute, Ludwig Institute for Cancer Research
- 3CEllular and MOlecular Division-Laboratory of Neuropharmacology, Institute of Neuroscience
- 4CEllular and MOlecular Division-Laboratory of Cell Physiology, Institute of Neuroscience, Université Catholique de Louvain, B-1200, Brussels, Belgium
- Correspondence should be addressed to Pascal Kienlen-Campard at pascal.kienlen-campard{at}uclouvain.be.
Author contributions
Author contributions: P.K.-C. designed research; R.O., S.C., F.P., R.G., B.T., P.D., M.V., C.V., A.D., and P.G. performed research; S.C., F.P., R.G., N.P., J.-N.O., P.G., S.S., and P.K.-C. analyzed data; R.O., S.S., and P.K.-C. wrote the paper.
↵* S.C. and F.P. contributed equally to this work.
Disclosures
The authors declare no competing financial interests.
This work was supported by the Belgian Fonds pour la Formation à la Recherche dans l’Industrie et l’Agriculture (FRIA-FNRS), the Interuniversity Attraction Pole Programme-Belgian Sate-Belgian Science Policy Grants IAP-P7/16 and IAP-P7/13, The Belgian Fonds de la Recherche Scientifique Médicale (FRSM), the Queen Elisabeth Medical Foundation (FMRE), the Fondation pour la Recherche sur la Maladie d’Alzheimer (SAO/FRA), and by the Concerted Research Action from the General Direction of Scientific Research of the French Community of Belgium Grants ARC 14/19-059 and ARC17/22-083.
Other Version
- You are viewing the most recent version of this article.
- previous version (April 23, 2020).
Online Impact